— Know what they know.
Not Investment Advice

VCYT NASDAQ

Veracyte, Inc.
1W: +16.2% 1M: +34.1% 3M: +26.8% YTD: +6.6% 1Y: +56.9% 3Y: +83.8% 5Y: +23.6%
$45.03
-0.16 (-0.35%)
 
Weekly Expected Move ±13.5%
$28 $33 $38 $44 $49
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 74 · $3.6B mcap · 79M float · 1.23% daily turnover · Short 69% of daily vol

📊 Key Metrics

TTM
$542M
Revenue
+16.9% YoY
$88M
Net Income
+166.3% YoY
$155M
Free Cash Flow
+97.3% YoY
72.3%
Gross Margin
17.1%
Op. Margin
20.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE7.1%
ROA6.5%
ROIC7.0%

Valuation

P/E40.7
P/B2.7
EV/EBITDA21.2

Leverage

Debt/Equity0.03
Current Ratio8.15
Interest Cov.0.0x

Quality Scores

Piotroski F8/9
Altman Z16.87
Beneish M-2.72

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms